Clinical Trial

Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management

Name: Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management — clinical trial record (NCT07464808)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to compare the efficacy of anti-Xa based versus weight-based enoxaparin dosing and to evaluate anti-Xa levels as a predictive tool for clinical outcomes in burn patients

Trial Details

NCT Number	NCT07464808
Lead Sponsor	Ain Shams University
Conditions	Venous Thromboembolic Event
Enrollment	25 participants
Start Date	2025-11-28
Primary Completion	2027-01-30 (estimated)
Study Completion	2027-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-11